These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25392457)

  • 21. Major neurological events following foam sclerotherapy.
    Bush RG; Derrick M; Manjoney D
    Phlebology; 2008; 23(4):189-92. PubMed ID: 18663119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid versus foam sclerotherapy.
    Hamel-Desnos C; Allaert FA
    Phlebology; 2009 Dec; 24(6):240-6. PubMed ID: 19952379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy.
    Frullini A; Felice F; Burchielli S; Di Stefano R
    Phlebology; 2011 Aug; 26(5):203-8. PubMed ID: 21478144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
    Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
    J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse neurological events after sodium tetradecyl sulfate foam sclerotherapy - A prospective, observational study of 8056 treatments.
    Davies HO; Watkins M; Oliver R; Berhane S; Bradbury AW
    Phlebology; 2022 Mar; 37(2):97-104. PubMed ID: 34657519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.
    Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
    J Vasc Surg; 2008 Apr; 47(4):830-6. PubMed ID: 18242937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foam sclerotherapy--a possible option in therapy of varicose veins.
    Kendler M; Wetzig T; Simon JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):648-54. PubMed ID: 17659037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Middle cerebral air embolism after foam sclerotherapy.
    Asbjornsen CB; Rogers CD; Russell BL
    Phlebology; 2012 Dec; 27(8):430-3. PubMed ID: 22368193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foam sclerotherapy.
    Alder G; Lees T
    Phlebology; 2015 Nov; 30(2 Suppl):18-23. PubMed ID: 26556698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the current role of foam sclerotherapy in treating reflux and varicosities?
    Wright DD
    Semin Vasc Surg; 2010 Jun; 23(2):123-6. PubMed ID: 20685568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Echo-guided compression sclerotherapy using foam: an improvement in the treatment of varicose veins].
    Kockaert MA; de Roos KP; Neumann HA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1758-63. PubMed ID: 16948234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of foam sclerotherapy for varicose veins.
    Jia X; Mowatt G; Burr JM; Cassar K; Cook J; Fraser C
    Br J Surg; 2007 Aug; 94(8):925-36. PubMed ID: 17636511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible neurological deficit after foam sclerotherapy.
    Hartmann K; Harms L; Simon M
    Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):648-9. PubMed ID: 19683463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foam sclerotherapy: investigating the need for sterile air.
    de Roos KP; Groen L; Leenders AC
    Dermatol Surg; 2011 Aug; 37(8):1119-24. PubMed ID: 21615606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Frullini A
    Dermatol Surg; 2011 Jan; 37(1):17-8. PubMed ID: 21214662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.